AGL Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.5B
+5.2%
1.4B
-9.5%
1.6B
+9.3%
1.4B
+2.9%
1.4B
Cost of Revenue
1.4B
+2.4%
1.4B
-18.4%
1.7B
+10.5%
1.5B
+3.8%
1.4B
Gross Profit
107.1M
+64.8%
65.0M
+171.7%
-90670000
-34.0%
-67646000
-29.0%
-52427000
Operating Expenses
95.4M
+56.3%
61.0M
-40.8%
103.2M
+62.1%
63.6M
+0.0%
63.6M
R&D
0
0
0
0
0
SG&A
88.5M
+63.2%
54.2M
-9.8%
60.1M
+6.9%
56.2M
-0.1%
56.3M
Operating Income
11.8M
+194.5%
4.0M
+102.1%
-193825000
-47.6%
-131274000
-13.1%
-116027000
EBITDA
18.6M
+72.8%
10.8M
+107.2%
-150771000
-21.7%
-123844000
-13.9%
-108708000
Net Income
18.0M
-63.3%
48.9M
+125.9%
-188882000
-71.4%
-110207000
-5.6%
-104370000
EPS (Basic)
$1.07
-63.7%
$2.95
+175.4%
$-3.91
+42.1%
$-6.75
-7.0%
$-6.31
EPS (Diluted)
$1.04
-64.6%
$2.94
+175.2%
$-3.91
+42.1%
$-6.75
-7.0%
$-6.31
Shares (Diluted)
17.2M
+3.3%
16.7M
-65.5%
48.3M
+191.5%
16.6M
+0.2%
16.6M
agilon health (AGL) โ€” Financials